Beam Therapeutics INC. (BEAM) SEC Filings — 2025
10 SEC filings for Beam Therapeutics INC. (BEAM) in 2025.
Filings
- Beam Therapeutics INC. 8-K Filing — 8-K · Dec 11, 2025
- Beam Therapeutics' Q3 Loss Widens Amid Soaring R&D Costs — 10-Q · Nov 4, 2025
- Beam Therapeutics' Q2 Loss Widens to $130.6M Amid R&D Surge — 10-Q · Aug 5, 2025
- Beam Therapeutics Reports Unregistered Equity Sale — 8-K · Jul 3, 2025
- Beam Therapeutics Files 8-K on Security Holder Vote — 8-K · Jun 6, 2025
- Beam Therapeutics Files Q1 2025 10-Q — 10-Q · May 6, 2025
- Beam Therapeutics Executive Compensation Details — DEF 14A · Apr 18, 2025
- Pfizer to Acquire Beam Therapeutics for $13B — 8-K · Mar 10, 2025
- Beam Therapeutics Files 2024 10-K — 10-K · Feb 25, 2025
- Beam Therapeutics Files 8-K on Financials and Operations — 8-K · Jan 13, 2025